Abstract：OBJECTIVE: To investigate the role of non-high density lipoprotein cholesterol (non-HDL-C) in the assessment of cardiovascular disease (CVD) risk factors such as hypertension, pre-diabetes and diabetes in obese children. METHODS: According to the presence of complications (hypertension, pre-diabetes and diabetes), 810 children with central obesity were divided into two groups: one group with complications (n=499) and one group without complications (n=311). One hundred and sixty-four age- and sex-matched children served as the control group. Logistic regression analysis and receiver operating characteristic (ROC) curves were used to analyze the detection of non-lipid CVD risk factors by seven lipid markers. RESULTS: The prevalence rates of hypertension and pre-diabetes were significantly higher in obese children with high non-HDL-C concentrations (≥3.76 mmol/L). After adjusting for waist circumference Z-scores, the area under the ROC curve for non-HDL-C was 0.680 to detect non-lipid CVD risk factors, while the areas for low-density lipoprotein cholesterol, total cholesterol and apoprotein B were 0.659, 0.669 and 0.647 respectively. CONCLUSIONS: Compared with the other lipid markers, non-HDL-C is a better predictor for non-lipid CVD risk factors in obese children. Measurement of non-HDL-C concentations is recommended for obese children.
CHEN Lian-Hui,ZHU Wei-Fen,LIANG Li et al. Non-high-density-cholesterol as a predictor of non-lipid cardiovascular disease risk factors in obese children[J]. CJCP, 2013, 15(5): 356-360.
［1］Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study［J］. JAMA, 2003, 290(17): 2271-2276.
［2］Huang K, Zou CC, Yang XZ, Chen XQ, Liang L. Carotid intima-media thickness and serum endothelial marker levels in obese children with metabolic syndrome［J］. Arch Pediatr Adolesc Med, 2010, 164(9): 846-851.
［3］Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report［J］.Pediatrics, 2011, 128(Suppl 5): S213-S256.
［5］Li C, Ford ES, McBride PE, Kwiterovich PO, McCrindle BW, Gidding SS. Non-high-density lipoprotein cholesterol concentration is associated with the metabolic syndrome among US youth aged 12-19 years［J］.J Pediatr, 2011, 158(2): 201-207.
［6］World Health Organization. WHO child growth standards:length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development［EB/OL］.［2006］. http://www.who.int/iris/handle/10665/43413.
［9］Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)［J］. JAMA, 2001, 285(19): 2486-2497.
［10］Morrison JA, Friedman LA, Wang P, Glueck CJ.Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later［J］. J Pediatr, 2008, 152(2): 201-206.
［11］Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later:the princeton lipid research clinics follow-up study［J］. Pediatrics, 2007, 120(2): 340-345.
［12］Siren R, Eriksson JG, Vanhanen H. Waist circumference a good indicator of future risk for type 2 diabetes and cardiovascular disease［J］.BMC Public Health, 2012, 12(1): 631.
［14］Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, et al. Lipoprotein(a) as a cardiovascular risk factor: current status［J］. Eur Heart J, 2010, 31(23): 2844-2853.
